|
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 23.50 USD | +0.09% |
|
-.--% | +159.10% |
| 17/06 | Assertio Holdings Completes Merger With Zydus Lifesciences | MT |
| 17/06 | Assertio Holdings, Inc. Announces Board and Committee Changes, Effective June 16, 2026 | CI |
| Market Cap | 15Cr 13Cr 12Cr 11Cr 21Cr 1.45TCr 22Cr 147.7Cr 58Cr 719.79Cr 57Cr 56Cr 2.49TCr | P/E 2027 * |
-
| P/E 2028 * | - |
|---|---|---|---|---|---|
| Enterprise Value | 13Cr 11Cr 11Cr 9.69Cr 18Cr 1.23TCr 19Cr 125.18Cr 49Cr 610.05Cr 48Cr 47Cr 2.11TCr | EV / Sales 2027 * |
-
| EV / Sales 2028 * | - |
| Free-Float |
98.57% | Yield 2027 * |
-
| Yield 2028 * | - |
Last Transcript: Assertio Holdings
| 1 day | +0.09% | ||
| 3 months | +30.19% | ||
| 6 months | +100.34% | ||
| Current year | +159.10% |
| Current year | 9.11 |  | 23.5 |
| 1 year | 8.61 | | 23.5 |
| 3 years | 7.71 | | 86.7 |
| 5 years | 7.71 | | 120.15 |
| 10 years | 7.71 | | 1,621.19 |
| Director | Title | Age | Since |
|---|---|---|---|
Ravi Yadavar
BRD | Director/Board Member | 26 | 16/06/2026 |
Punit Patel
BRD | Director/Board Member | - | 16/06/2026 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 05/05/26 | Free | Director | 4,851 | 0.0753% | ||
| 02/03/26 | Free | Chief Financial Officer | 39,932 | 0.6223% | ||
| 21/02/26 | Fiscal year | Chairperson | 2,852 | 0.0444% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +0.09% | -.--% | +120.44% | -72.42% | 15Cr | |
| -4.31% | -2.32% | +52.39% | +154.83% | 1,07900Cr | |
| -3.47% | -1.22% | +53.11% | +52.87% | 64TCr | |
| -2.49% | -0.31% | +35.30% | +71.23% | 47TCr | |
| -2.35% | +1.17% | +36.21% | +30.67% | 35TCr | |
| -2.24% | -0.61% | +33.53% | +39.32% | 30TCr | |
| -3.30% | +0.22% | +10.59% | +13.68% | 27TCr | |
| -2.12% | +3.31% | +1.82% | -39.41% | 23TCr | |
| -1.43% | +2.52% | +26.37% | +62.65% | 21TCr | |
| -2.32% | -1.23% | +12.62% | +69.75% | 16TCr | |
| Average | -2.44% | +4.38% | +38.24% | +38.32% | 37.1TCr | |
| Weighted average by Cap. | -3.15% | +4.86% | +37.92% | +74.39% |
| 2027 * | 2028 * | |
|---|---|---|
| Net sales | - | - |
| Net income | 4L 4L 3L 3L 6L 3.83Cr 6L 38.9L 15.21L 1.9Cr 15.02L 14.69L 6.55Cr | - |
| Net Debt | - | - |
Employees
53
Sector
Pharmaceuticals
- Stock Market
- Stocks
- ASRT Stock
Select your edition
All financial news and data tailored to specific country editions
